BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ploux S, Varma N, Strik M, Lazarus A, Bordachar P. Optimizing Implantable Cardioverter-Defibrillator Remote Monitoring: A Practical Guide. JACC Clin Electrophysiol 2017;3:315-28. [PMID: 29759443 DOI: 10.1016/j.jacep.2017.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Daley C, Toscos T, Allmandinger T, Ahmed R, Wagner S, Mirro M. Organizational Models for Cardiac Implantable Electronic Device Remote Monitoring: Current and Future Directions. Card Electrophysiol Clin 2021;13:483-97. [PMID: 34330375 DOI: 10.1016/j.ccep.2021.04.008] [Reference Citation Analysis]
2 Geller JC, Lewalter T, Bruun NE, Taborsky M, Bode F, Nielsen JC, Stellbrink C, Schön S, Mühling H, Oswald H, Reif S, Kääb S, Illes P, Proff J, Dagres N, Hindricks G; IN-TIME Study Group. Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial. Clin Res Cardiol 2019;108:1117-27. [PMID: 30874886 DOI: 10.1007/s00392-019-01447-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
3 Ono M, Varma N. Remote monitoring to Improve long-term prognosis in heart failure patients with implantable cardioverter-defibrillators. Expert Rev Med Devices 2017;14:335-42. [PMID: 28299956 DOI: 10.1080/17434440.2017.1306438] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
4 Cohen IG, Gerke S, Kramer DB. Ethical and Legal Implications of Remote Monitoring of Medical Devices. Milbank Q 2020;98:1257-89. [PMID: 33078879 DOI: 10.1111/1468-0009.12481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Biswas M, Levy A, Weber R, Tarakji K, Chung M, Noseworthy PA, Newton-Cheh C, Rosenberg MA. Multicenter Analysis of Dosing Protocols for Sotalol Initiation. J Cardiovasc Pharmacol Ther 2020;25:212-8. [PMID: 31707834 DOI: 10.1177/1074248419887710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Galiero R, Pafundi PC, Nevola R, Rinaldi L, Acierno C, Caturano A, Salvatore T, Adinolfi LE, Costagliola C, Sasso FC. The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy. J Diabetes Res. 2020;2020:9036847. [PMID: 33123599 DOI: 10.1155/2020/9036847] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
7 Zaman J, Agarwal S. Management of ventricular tachycardia storm. Heart 2021:heartjnl-2019-316192. [PMID: 34257075 DOI: 10.1136/heartjnl-2019-316192] [Reference Citation Analysis]
8 Liljeroos M, Thylén I, Strömberg A. Patients' and Nurses' Experiences and Perceptions of Remote Monitoring of Implantable Cardiac Defibrillators in Heart Failure: Cross-Sectional, Descriptive, Mixed Methods Study. J Med Internet Res 2020;22:e19550. [PMID: 32985997 DOI: 10.2196/19550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Braunschweig F, Anker SD, Proff J, Varma N. Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead? Europace 2019;21:846-55. [PMID: 30903152 DOI: 10.1093/europace/euz011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Ono M, Varma N. Remote Monitoring for Chronic Disease Management. Cardiac Electrophysiology Clinics 2018;10:43-58. [DOI: 10.1016/j.ccep.2017.11.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
11 Mascarenhas DAN, Mudumbi PC, Kantharia BK. Outpatient Initiation of Sotalol in Patients with Atrial Fibrillation: Utility of Cardiac Implantable Electronic Devices for Therapy Monitoring. Am J Cardiovasc Drugs 2021. [PMID: 34291437 DOI: 10.1007/s40256-021-00493-7] [Reference Citation Analysis]